BioStem Technologies, Inc.

BSEM · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$22,833$239$772$340
Short-Term Investments$0$0$0$0
Receivables$106,230$11,372$37$300
Inventory$1,824$659$395$260
Other Curr. Assets$2,874$329$282$38
Total Curr. Assets$133,761$12,599$1,487$939
Property Plant & Equip (Net)$1,966$1,369$1,373$1,278
Goodwill$245$245$245$245
Intangibles$224$348$363$210
Long-Term Investments$0-$348$0$0
Tax Assets$4,354$0$111$0
Other NC Assets$0$348-$111$0
Total NC Assets$6,789$1,961$1,980$1,733
Other Assets$0$0$0$0
Total Assets$140,550$14,560$3,466$2,672
Liabilities
Payables$5,290$1,392$49$647
Short-Term Debt$4,171$4,490$4,121$3,027
Tax Payable$0$0$0$0
Deferred Revenue$0$9$8$2,469
Other Curr. Liab.$89,709$9,730$2,150$1,565
Total Curr. Liab.$99,170$15,621$6,328$6,541
LT Debt$330$284$1,088$1,804
Deferred Rev, NC$0$0-$111$0
Deferred Tax Liab, NC$174$0$111$0
Other NC Liab.$0$0$0$120
Total NC Liab.$505$284$1,088$1,925
Other Liabilities$0$0$0$0
Cap. Leases$287$63$141$33
Total Liabilities$99,674$15,905$7,416$8,466
Equity
Pref Stock$0$0$0$0
Common Stock$17$16$12$10
Retained Earnings-$13,740-$45,624-$37,023-$29,948
AOCI$0$0$0$0
Other Equity$54,599$44,264$32,934$23,979
Total Equity$40,876-$1,344-$4,076-$5,959
Supplemental Information
Minority Interest$0$0$126$165
Total Liab. & Tot. Equity$140,550$14,560$3,466$2,672
Net Debt-$18,331$4,535$4,437$4,491